Moreover, pre-treatment of osteosarcoma cells with the PXR antagonist ketoconazole, before exposure to etoposide, significantly increased the sensitivity of these cells to certain chemotherapeutic agents [60]. This evidence concerns the gene NR1I2 and osteosarcoma.